Valproate and lithium: Old drugs for new pharmacological approaches in brain tumors?

被引:11
作者
Natale, Gianfranco [1 ,2 ]
Fini, Elisabetta [3 ]
Calabro, Pasquale Fabio [3 ]
Carli, Marco [1 ]
Scarselli, Marco [1 ]
Bocci, Guido [3 ]
机构
[1] Univ Pisa, Dept Translat Res & New Technol Med & Surg, Pisa, Italy
[2] Univ Pisa, Museum Human Anat Filippo Civinini, Pisa, Italy
[3] Univ Pisa, Dept Clin & Expt Med, Pisa, Italy
关键词
Valproate; Valproic acid; Lithium carbonate; Lithium chloride; Brain; Cancer; Preclinical research; Drug repositioning; Clinical studies; Therapeutic drug monitoring; Adverse drug reactions; GLYCOGEN-SYNTHASE KINASE-3; RADIATION-THERAPY; ACID SUPPRESSES; LEUKEMIC-CELLS; CANCER CELLS; IN-VITRO; APOPTOSIS; SURVIVAL; GROWTH; GLIOBLASTOMA;
D O I
10.1016/j.canlet.2023.216125
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Beyond its use as an antiepileptic drug, over time valproate has been increasingly used for several other ther-apeutic applications. Among these, the antineoplastic effects of valproate have been assessed in several in vitro and in vivo preclinical studies, suggesting that this agent significantly inhibits cancer cell proliferation by modulating multiple signaling pathways. During the last years various clinical trials have tried to find out if valproate co-administration could enhance the antineoplastic activity of chemotherapy in glioblastoma patients and in patients suffering from brain metastases, demonstrating that the inclusion of valproate in the therapeutic schedule causes an improved median overall survival in some studies, but not in others. Thus, the effects of the use of concomitant valproate in brain cancer patients are still controversial. Similarly, lithium has been tested as an anticancer drug in several preclinical studies mainly using the un-registered formulation of lithium chloride salts. Although, there are no data showing that the anticancer effects of lithium chloride are superimposable to the registered lithium carbonate, this formulation has shown preclinical activity in glioblastoma and hepatocellular cancers. However, few but interesting clinical trials have been per-formed with lithium carbonate on a very small number of cancer patients. Based on published data, valproate could represent a potential complementary therapeutic approach to enhance the anticancer activity of brain cancer standard chemotherapy. Same advantageous characteristics are less convincing for lithium carbonate. Therefore, the planning of specific phase III studies is necessary to validate the repositioning of these drugs in present and future oncological research.
引用
收藏
页数:9
相关论文
共 108 条
[91]   Drugs Repurposing in High-Grade Serous Ovarian Cancer [J].
Torralba, Manuel ;
Farra, Rossella ;
Maddaloni, Marianna ;
Grassi, Mario ;
Dapas, Barbara ;
Grassi, Gabriele .
CURRENT MEDICINAL CHEMISTRY, 2020, 27 (42) :7222-7233
[92]   Phase I Trial of Lithium and Tretinoin for Treatment of Relapsed and Refractory Non-promyelocytic Acute Myeloid Leukemia [J].
Ueda, Masumi ;
Stefan, Tammy ;
Stetson, Lindsay ;
Ignatz-Hoover, James J. ;
Tomlinson, Benjamin ;
Creger, Richard J. ;
Cooper, Brenda ;
Lazarus, Hillard M. ;
de Lima, Marcos ;
Wald, David N. ;
Caimi, Paolo F. .
FRONTIERS IN ONCOLOGY, 2020, 10
[93]   Interactions between antiepileptic and chemotherapeutic drugs [J].
Vecht, CJ ;
Wagner, GL ;
Wilms, EB .
LANCET NEUROLOGY, 2003, 2 (07) :404-409
[94]   Valproic acid reduces hair loss and improves survival in patients receiving temozolomide-based radiation therapy for high-grade glioma [J].
Watanabe, Shinichi ;
Kuwabara, Yui ;
Suehiro, Satoshi ;
Yamashita, Daisuke ;
Tanaka, Mamoru ;
Tanaka, Akihiro ;
Ohue, Shiro ;
Araki, Hiroaki .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 73 (03) :357-363
[95]   Valproic Acid and Breast Cancer: State of the Art in 2021 [J].
Wawruszak, Anna ;
Halasa, Marta ;
Okon, Estera ;
Kukula-Koch, Wirginia ;
Stepulak, Andrzej .
CANCERS, 2021, 13 (14)
[96]   Prolonged survival with valproic acid use in the EORTC/NCIC temozolomide trial for glioblastoma [J].
Weller, M. ;
Gorlia, T. ;
Cairncross, J. G. ;
van den Bent, M. J. ;
Mason, W. ;
Belanger, K. ;
Brandes, A. A. ;
Bogdahn, U. ;
Macdonald, D. R. ;
Forsyth, P. ;
Rossetti, A. O. ;
Lacombe, D. ;
Mirimanoff, R. -O. ;
Vecht, C. J. ;
Stupp, R. .
NEUROLOGY, 2011, 77 (12) :1156-1164
[97]  
Wu EX, 2013, CURR MED CHEM, V20, P4093
[98]   Tissue inhibitor of metalloproteinase 2 inhibits activation of the β-catenin signaling in melanoma cells [J].
Xia, Yuxuan ;
Wu, Shaoping .
CELL CYCLE, 2015, 14 (11) :1666-1674
[99]   Lithium as an Adjuvant in the Postoperative Ablation of Remnant Tissue in Low-Risk Thyroid Carcinoma [J].
Yamazaki, Claudia Akemi ;
Padovani, Rosalia P. ;
Mello Biscolla, Rosa Paula ;
Ikejiri, Elza Setsuko ;
Marchetti, Renata Rosa ;
Castiglioni, Mario Luiz V. ;
Matsumura, Luiza Kimiko ;
de Barros Maciel, Rui Monteiro ;
Furlanetto, Reinaldo Perrone .
THYROID, 2012, 22 (10) :1002-1006
[100]   Valproic Acid Inhibits Glioma and Its Mechanisms [J].
Yang, Zhao-Yu ;
Wang, Xiao-Hong .
JOURNAL OF HEALTHCARE ENGINEERING, 2022, 2022